During the past decade, Toronto Sunnybrook Regional Cancer Centre conducted 121 clinical trials. In the 10-year time frame, 121 clinical trials started and 84 clinical trials were completed, i.e. on average, 69.4% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 41 clinical trials were completed. i.e. 132.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toronto Sunnybrook Regional Cancer Centre" #1 sponsor was "NCIC Clinical Trials Group" with 49 trials, followed by "Sunnybrook Health Sciences Centre" with 45 trials sponsored, "Radiation Therapy Oncology Group" with 38 trials sponsored, "Canadian Cancer Trials Group" with 26 trials sponsored and "Ontario Clinical Oncology Group (OCOG)" with 26 trials sponsored. Other sponsors include 152 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toronto Sunnybrook Regional Cancer Centre" #1 collaborator was "National Cancer Institute (NCI)" with 95 trials as a collaborator, "NCIC Clinical Trials Group" with 23 trials as a collaborator, "SWOG Cancer Research Network" with 19 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator and "Canadian Cancer Trials Group" with 13 trials as a collaborator. Other collaborators include 237 different institutions and companies that were collaborators in the rest 139 trials.

According to Clinical.Site data, the most researched conditions in "Toronto Sunnybrook Regional Cancer Centre" are "Breast Cancer" (48 trials), "Prostate Cancer" (40 trials), "Colorectal Cancer" (16 trials), "Lymphoma" (15 trials) and "Brain and Central Nervous System Tumors" (11 trials). Many other conditions were trialed in "Toronto Sunnybrook Regional Cancer Centre" in a lesser frequency.

Most popular intervention types in "Toronto Sunnybrook Regional Cancer Centre" are "Drug" (213 trials), "Radiation" (106 trials), "Other" (66 trials), "Procedure" (55 trials) and "Biological" (45 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (40 trials), "Placebo" (20 trials), "Laboratory Biomarker Analysis" (15 trials), "Quality-of-Life Assessment" (15 trials) and "cisplatin" (14 trials). Other intervention names were less common.

The vast majority of trials in "Toronto Sunnybrook Regional Cancer Centre" are 209 trials for "All" genders, 81 trials for "Female" genders and 51 trials for "Male" genders.

Currently, there are NaN active trials in "Toronto Sunnybrook Regional Cancer Centre". 1 are not yet recruiting, 36 are recruiting, 58 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 207 completed trials in Toronto Sunnybrook Regional Cancer Centre, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Toronto Sunnybrook Regional Cancer Centre, 31 "Phase 1" clinical trials were conducted, 112 "Phase 2" clinical trials and 147 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 51 trials that are defined as “Not Applicable".